680 related articles for article (PubMed ID: 18319702)
1. Assessment of myocardial viability in ischemic heart disease by cardiac magnetic resonance imaging.
Muellerleile K; Barmeyer A; Groth M; Lund GK
Minerva Cardioangiol; 2008 Apr; 56(2):237-49. PubMed ID: 18319702
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of cardiac magnetic resonance imaging in assessing myocardial viability.
Kwong RY; Korlakunta H
Top Magn Reson Imaging; 2008 Feb; 19(1):15-24. PubMed ID: 18690157
[TBL] [Abstract][Full Text] [Related]
3. MRI assessment of myocardial viability: comparison with other imaging techniques.
Baer FM; Theissen P; Schneider CA; Kettering K; Voth E; Sechtem U; Schicha H
Rays; 1999; 24(1):96-108. PubMed ID: 10358387
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging in determination of myocardial ischemia and viability: comparison with positron emission tomography and single-photon emission computed tomography in a porcine model.
Wang L; Zhu HY; Tian JM; Huang SD; Kong LS; Lu JP
Acta Radiol; 2007 Jun; 48(5):500-7. PubMed ID: 17520425
[TBL] [Abstract][Full Text] [Related]
5. [Cine magnetic resonance with dobutamine following a myocardial infarct].
Giovagnoni A; Ligabue G; Rossi R; Muia N; Modena MG; Romagnoli R
Radiol Med; 1999 Dec; 98(6):482-9. PubMed ID: 10755009
[TBL] [Abstract][Full Text] [Related]
6. Myocardial viability in ischemic heart disease: new directions and perspectives.
Previtali M
Ital Heart J; 2001 Feb; 2(2):93-9. PubMed ID: 11256549
[TBL] [Abstract][Full Text] [Related]
7. Assessment of myocardial viability in chronic ischemic heart disease: current status.
Rizzello V; Poldermans D; Bax JJ
Q J Nucl Med Mol Imaging; 2005 Mar; 49(1):81-96. PubMed ID: 15724138
[TBL] [Abstract][Full Text] [Related]
8. Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(16):1-80. PubMed ID: 23074393
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
Hunold P; Brandt-Mainz K; Freudenberg L; Vogt FM; Neumann T; Knipp S; Barkhausen J
Rofo; 2002 Jul; 174(7):867-73. PubMed ID: 12101477
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of contrast-enhanced magnetic resonance imaging and single-photon emission computed tomography for detection of myocardial necrosis early after acute myocardial infarction.
Ibrahim T; Bülow HP; Hackl T; Hörnke M; Nekolla SG; Breuer M; Schömig A; Schwaiger M
J Am Coll Cardiol; 2007 Jan; 49(2):208-16. PubMed ID: 17222732
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance tomography imaging techniques for diagnosing myocardial vitality].
Baer FM; Theissen P; Schneider CA; Voth E; Schicha H; Sechtem U
Herz; 1994 Feb; 19(1):51-64. PubMed ID: 8150414
[TBL] [Abstract][Full Text] [Related]
12. Myocardial contractile response to increasing doses of dobutamine in patients with reperfused acute myocardial infarction by cardiac magnetic resonance imaging.
Barmeyer AA; Stork A; Bansmann M; Muellerleile K; Bavastro M; Heuer M; Adam G; Meinertz T; Lund GK
Cardiology; 2008; 110(3):153-9. PubMed ID: 18057882
[TBL] [Abstract][Full Text] [Related]
13. Impact of scar thickness on the assessment of viability using dobutamine echocardiography and thallium single-photon emission computed tomography: a comparison with contrast-enhanced magnetic resonance imaging.
Nelson C; McCrohon J; Khafagi F; Rose S; Leano R; Marwick TH
J Am Coll Cardiol; 2004 Apr; 43(7):1248-56. PubMed ID: 15063438
[TBL] [Abstract][Full Text] [Related]
14. MRI for the assessment of myocardial viability.
Weinsaft JW; Klem I; Judd RM
Cardiol Clin; 2007 Feb; 25(1):35-56, v. PubMed ID: 17478239
[TBL] [Abstract][Full Text] [Related]
15. Extent of myocardial scarring on nonstress delayed-contrast-enhancement cardiac magnetic resonance imaging correlates directly with degrees of resting regional dysfunction in chronic ischemic heart disease.
Srichai MB; Schvartzman PR; Sturm B; Kasper JM; Lieber ML; White RD
Am Heart J; 2004 Aug; 148(2):342-8. PubMed ID: 15309007
[TBL] [Abstract][Full Text] [Related]
16. Technology insight: assessment of myocardial viability by delayed-enhancement magnetic resonance imaging.
Judd RM; Wagner A; Rehwald WG; Albert T; Kim RJ
Nat Clin Pract Cardiovasc Med; 2005 Mar; 2(3):150-8. PubMed ID: 16265459
[TBL] [Abstract][Full Text] [Related]
17. Myocardial viability and revascularization.
Kanderian AS; Renapurkar R; Flamm SD
Heart Fail Clin; 2009 Jul; 5(3):333-48, vi. PubMed ID: 19564012
[TBL] [Abstract][Full Text] [Related]
18. Functional outcome after revascularization in patients with chronic ischemic heart disease: a quantitative late gadolinium enhancement CMR study evaluating transmural scar extent, wall thickness and periprocedural necrosis.
Bondarenko O; Beek AM; Nijveldt R; McCann GP; van Dockum WG; Hofman MB; Twisk JW; Visser CA; van Rossum AC
J Cardiovasc Magn Reson; 2007; 9(5):815-21. PubMed ID: 17891620
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of cardiac magnetic resonance viability indexes to predict functional recovery after successful percutaneous coronary intervention in acute myocardial infarction.
Gerbaud E; Faury A; Coste P; Erickson M; Corneloup O; Dos Santos P; Durrieu-Jaïs C; Laurent F; Montaudon M
Am J Cardiol; 2010 Mar; 105(5):598-604. PubMed ID: 20185003
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging for the assessment of myocardial viability.
Thomson LE; Kim RJ; Judd RM
J Magn Reson Imaging; 2004 Jun; 19(6):771-88. PubMed ID: 15170783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
